nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—Benzphetamine—obesity	0.427	1	CrCtD
Fentanyl—Trimethaphan—Benzphetamine—obesity	0.0321	0.111	CrCrCtD
Fentanyl—Bepridil—Benzphetamine—obesity	0.0251	0.0864	CrCrCtD
Fentanyl—CYP3A7—Cimetidine—obesity	0.0241	0.181	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Cimetidine—obesity	0.0241	0.181	CbGbCtD
Fentanyl—Phenylbutazone—Benzphetamine—obesity	0.0207	0.0715	CrCrCtD
Fentanyl—Propafenone—Benzphetamine—obesity	0.0199	0.0687	CrCrCtD
Fentanyl—Alverine—Benzphetamine—obesity	0.0199	0.0687	CrCrCtD
Fentanyl—Benzatropine—Benzphetamine—obesity	0.0184	0.0636	CrCrCtD
Fentanyl—CYP3A5—Cimetidine—obesity	0.0181	0.136	CbGbCtD
Fentanyl—Eprazinone—Benzphetamine—obesity	0.0172	0.0594	CrCrCtD
Fentanyl—Antazoline—Benzphetamine—obesity	0.0172	0.0594	CrCrCtD
Fentanyl—CYP3A4—Sibutramine—obesity	0.0149	0.112	CbGbCtD
Fentanyl—Dextropropoxyphene—Benzphetamine—obesity	0.0137	0.0471	CrCrCtD
Fentanyl—Phenoxybenzamine—Benzphetamine—obesity	0.0137	0.0471	CrCrCtD
Fentanyl—Diphenidol—Benzphetamine—obesity	0.0137	0.0471	CrCrCtD
Fentanyl—Diphenylpyraline—Benzphetamine—obesity	0.013	0.0449	CrCrCtD
Fentanyl—Modafinil—Benzphetamine—obesity	0.0127	0.0439	CrCrCtD
Fentanyl—Benzphetamine—Methamphetamine—obesity	0.0121	0.0416	CrCrCtD
Fentanyl—ABCB1—Cimetidine—obesity	0.0118	0.0882	CbGbCtD
Fentanyl—Cyclizine—Benzphetamine—obesity	0.0117	0.0402	CrCrCtD
Fentanyl—Methadone—Benzphetamine—obesity	0.0114	0.0394	CrCrCtD
Fentanyl—CYP3A4—Benzphetamine—obesity	0.0113	0.0847	CbGbCtD
Fentanyl—CYP3A4—Bupropion—obesity	0.00961	0.072	CbGbCtD
Fentanyl—Benzyl Benzoate—Benzphetamine—obesity	0.00886	0.0306	CrCrCtD
Fentanyl—Diphenhydramine—Benzphetamine—obesity	0.00849	0.0293	CrCrCtD
Fentanyl—CYP3A4—Orlistat—obesity	0.00783	0.0587	CbGbCtD
Fentanyl—CYP3A4—Cimetidine—obesity	0.00705	0.0529	CbGbCtD
Fentanyl—CYP3A4—Topiramate—obesity	0.00462	0.0346	CbGbCtD
Fentanyl—Loperamide—POMC—obesity	0.000203	0.177	CrCbGaD
Fentanyl—Benazepril—MTHFR—obesity	0.000142	0.124	CrCbGaD
Fentanyl—Trimethaphan—BCHE—obesity	0.000137	0.12	CrCbGaD
Fentanyl—Quinapril—ACE—obesity	0.000133	0.116	CrCbGaD
Fentanyl—Benazepril—ACE—obesity	0.000115	0.101	CrCbGaD
Fentanyl—Propafenone—ADRB1—obesity	7.98e-05	0.0697	CrCbGaD
Fentanyl—Phenoxybenzamine—SLC22A1—obesity	7.3e-05	0.0638	CrCbGaD
Fentanyl—Alfentanil—ALB—obesity	7.17e-05	0.0627	CrCbGaD
Fentanyl—Diphenhydramine—SLC22A1—obesity	6.12e-05	0.0535	CrCbGaD
Fentanyl—Phenoxybenzamine—ADRB2—obesity	4.66e-05	0.0407	CrCbGaD
Fentanyl—Methadone—CYP19A1—obesity	4.4e-05	0.0384	CrCbGaD
Fentanyl—Abdominal pain upper—Topiramate—obesity	4.13e-05	0.000404	CcSEcCtD
Fentanyl—Discomfort—Sibutramine—obesity	4.13e-05	0.000403	CcSEcCtD
Fentanyl—Hypokalaemia—Topiramate—obesity	4.12e-05	0.000402	CcSEcCtD
Fentanyl—Muscle spasms—Bupropion—obesity	4.11e-05	0.000402	CcSEcCtD
Fentanyl—Infection—Orlistat—obesity	4.11e-05	0.000402	CcSEcCtD
Fentanyl—Breast disorder—Topiramate—obesity	4.09e-05	0.000399	CcSEcCtD
Fentanyl—Dry mouth—Sibutramine—obesity	4.08e-05	0.000399	CcSEcCtD
Fentanyl—Aspartate aminotransferase increased—Topiramate—obesity	4.07e-05	0.000398	CcSEcCtD
Fentanyl—Nervous system disorder—Orlistat—obesity	4.06e-05	0.000396	CcSEcCtD
Fentanyl—Nasopharyngitis—Topiramate—obesity	4.05e-05	0.000395	CcSEcCtD
Fentanyl—Confusional state—Sibutramine—obesity	4.04e-05	0.000394	CcSEcCtD
Fentanyl—Vision blurred—Bupropion—obesity	4.03e-05	0.000394	CcSEcCtD
Fentanyl—Skin disorder—Orlistat—obesity	4.02e-05	0.000393	CcSEcCtD
Fentanyl—Tremor—Bupropion—obesity	4.01e-05	0.000392	CcSEcCtD
Fentanyl—Gastritis—Topiramate—obesity	4e-05	0.000391	CcSEcCtD
Fentanyl—Anaphylactic shock—Sibutramine—obesity	4e-05	0.000391	CcSEcCtD
Fentanyl—Oedema—Sibutramine—obesity	4e-05	0.000391	CcSEcCtD
Fentanyl—Hyperhidrosis—Orlistat—obesity	4e-05	0.000391	CcSEcCtD
Fentanyl—Muscular weakness—Topiramate—obesity	3.99e-05	0.00039	CcSEcCtD
Fentanyl—Infection—Sibutramine—obesity	3.98e-05	0.000389	CcSEcCtD
Fentanyl—Ill-defined disorder—Bupropion—obesity	3.97e-05	0.000388	CcSEcCtD
Fentanyl—Anaemia—Bupropion—obesity	3.95e-05	0.000386	CcSEcCtD
Fentanyl—Shock—Sibutramine—obesity	3.94e-05	0.000385	CcSEcCtD
Fentanyl—Abdominal distension—Topiramate—obesity	3.94e-05	0.000385	CcSEcCtD
Fentanyl—Agitation—Bupropion—obesity	3.93e-05	0.000384	CcSEcCtD
Fentanyl—Thrombocytopenia—Sibutramine—obesity	3.92e-05	0.000383	CcSEcCtD
Fentanyl—Asthma—Topiramate—obesity	3.91e-05	0.000382	CcSEcCtD
Fentanyl—Dysphagia—Topiramate—obesity	3.91e-05	0.000382	CcSEcCtD
Fentanyl—Tachycardia—Sibutramine—obesity	3.91e-05	0.000382	CcSEcCtD
Fentanyl—Skin disorder—Sibutramine—obesity	3.89e-05	0.00038	CcSEcCtD
Fentanyl—Hyperhidrosis—Sibutramine—obesity	3.87e-05	0.000378	CcSEcCtD
Fentanyl—Malaise—Bupropion—obesity	3.86e-05	0.000377	CcSEcCtD
Fentanyl—Phenylbutazone—PTGS2—obesity	3.85e-05	0.0336	CrCbGaD
Fentanyl—Vertigo—Bupropion—obesity	3.84e-05	0.000375	CcSEcCtD
Fentanyl—Syncope—Bupropion—obesity	3.84e-05	0.000375	CcSEcCtD
Fentanyl—Leukopenia—Bupropion—obesity	3.83e-05	0.000374	CcSEcCtD
Fentanyl—Anorexia—Sibutramine—obesity	3.82e-05	0.000373	CcSEcCtD
Fentanyl—Angina pectoris—Topiramate—obesity	3.81e-05	0.000372	CcSEcCtD
Fentanyl—Sweating increased—Topiramate—obesity	3.81e-05	0.000372	CcSEcCtD
Fentanyl—Palpitations—Bupropion—obesity	3.78e-05	0.000369	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Orlistat—obesity	3.77e-05	0.000368	CcSEcCtD
Fentanyl—Bronchitis—Topiramate—obesity	3.76e-05	0.000367	CcSEcCtD
Fentanyl—Loss of consciousness—Bupropion—obesity	3.76e-05	0.000367	CcSEcCtD
Fentanyl—Abdominal discomfort—Topiramate—obesity	3.75e-05	0.000366	CcSEcCtD
Fentanyl—Insomnia—Orlistat—obesity	3.74e-05	0.000366	CcSEcCtD
Fentanyl—Hypotension—Sibutramine—obesity	3.74e-05	0.000366	CcSEcCtD
Fentanyl—Cough—Bupropion—obesity	3.73e-05	0.000365	CcSEcCtD
Fentanyl—Paraesthesia—Orlistat—obesity	3.71e-05	0.000363	CcSEcCtD
Fentanyl—Pancytopenia—Topiramate—obesity	3.71e-05	0.000363	CcSEcCtD
Fentanyl—Convulsion—Bupropion—obesity	3.71e-05	0.000362	CcSEcCtD
Fentanyl—Hypertension—Bupropion—obesity	3.69e-05	0.000361	CcSEcCtD
Fentanyl—Neutropenia—Topiramate—obesity	3.66e-05	0.000357	CcSEcCtD
Fentanyl—Dysuria—Topiramate—obesity	3.66e-05	0.000357	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Sibutramine—obesity	3.65e-05	0.000356	CcSEcCtD
Fentanyl—Dyspepsia—Orlistat—obesity	3.64e-05	0.000356	CcSEcCtD
Fentanyl—Chest pain—Bupropion—obesity	3.64e-05	0.000356	CcSEcCtD
Fentanyl—Arthralgia—Bupropion—obesity	3.64e-05	0.000356	CcSEcCtD
Fentanyl—Myalgia—Bupropion—obesity	3.64e-05	0.000356	CcSEcCtD
Fentanyl—Upper respiratory tract infection—Topiramate—obesity	3.63e-05	0.000355	CcSEcCtD
Fentanyl—Anxiety—Bupropion—obesity	3.63e-05	0.000355	CcSEcCtD
Fentanyl—Insomnia—Sibutramine—obesity	3.62e-05	0.000354	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	3.62e-05	0.000353	CcSEcCtD
Fentanyl—Pollakiuria—Topiramate—obesity	3.61e-05	0.000353	CcSEcCtD
Fentanyl—Erectile dysfunction—Topiramate—obesity	3.6e-05	0.000352	CcSEcCtD
Fentanyl—Discomfort—Bupropion—obesity	3.6e-05	0.000351	CcSEcCtD
Fentanyl—Decreased appetite—Orlistat—obesity	3.6e-05	0.000351	CcSEcCtD
Fentanyl—Paraesthesia—Sibutramine—obesity	3.6e-05	0.000351	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Orlistat—obesity	3.57e-05	0.000349	CcSEcCtD
Fentanyl—Dyspnoea—Sibutramine—obesity	3.57e-05	0.000349	CcSEcCtD
Fentanyl—Fatigue—Orlistat—obesity	3.57e-05	0.000348	CcSEcCtD
Fentanyl—Dry mouth—Bupropion—obesity	3.56e-05	0.000348	CcSEcCtD
Fentanyl—Somnolence—Sibutramine—obesity	3.56e-05	0.000348	CcSEcCtD
Fentanyl—Weight increased—Topiramate—obesity	3.56e-05	0.000348	CcSEcCtD
Fentanyl—Weight decreased—Topiramate—obesity	3.54e-05	0.000346	CcSEcCtD
Fentanyl—Pain—Orlistat—obesity	3.54e-05	0.000346	CcSEcCtD
Fentanyl—Hyperglycaemia—Topiramate—obesity	3.53e-05	0.000345	CcSEcCtD
Fentanyl—Dyspepsia—Sibutramine—obesity	3.52e-05	0.000344	CcSEcCtD
Fentanyl—Confusional state—Bupropion—obesity	3.52e-05	0.000344	CcSEcCtD
Fentanyl—Pneumonia—Topiramate—obesity	3.51e-05	0.000343	CcSEcCtD
Fentanyl—Oedema—Bupropion—obesity	3.49e-05	0.000341	CcSEcCtD
Fentanyl—Anaphylactic shock—Bupropion—obesity	3.49e-05	0.000341	CcSEcCtD
Fentanyl—Infestation NOS—Topiramate—obesity	3.49e-05	0.000341	CcSEcCtD
Fentanyl—Infestation—Topiramate—obesity	3.49e-05	0.000341	CcSEcCtD
Fentanyl—Decreased appetite—Sibutramine—obesity	3.48e-05	0.00034	CcSEcCtD
Fentanyl—Depression—Topiramate—obesity	3.48e-05	0.00034	CcSEcCtD
Fentanyl—Infection—Bupropion—obesity	3.47e-05	0.000339	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Topiramate—obesity	3.46e-05	0.000338	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Sibutramine—obesity	3.46e-05	0.000338	CcSEcCtD
Fentanyl—Shock—Bupropion—obesity	3.43e-05	0.000336	CcSEcCtD
Fentanyl—Renal failure—Topiramate—obesity	3.43e-05	0.000335	CcSEcCtD
Fentanyl—Pain—Sibutramine—obesity	3.42e-05	0.000335	CcSEcCtD
Fentanyl—Constipation—Sibutramine—obesity	3.42e-05	0.000335	CcSEcCtD
Fentanyl—Nervous system disorder—Bupropion—obesity	3.42e-05	0.000334	CcSEcCtD
Fentanyl—Neuropathy peripheral—Topiramate—obesity	3.42e-05	0.000334	CcSEcCtD
Fentanyl—Thrombocytopenia—Bupropion—obesity	3.42e-05	0.000334	CcSEcCtD
Fentanyl—Feeling abnormal—Orlistat—obesity	3.41e-05	0.000333	CcSEcCtD
Fentanyl—Tachycardia—Bupropion—obesity	3.41e-05	0.000333	CcSEcCtD
Fentanyl—Stomatitis—Topiramate—obesity	3.4e-05	0.000332	CcSEcCtD
Fentanyl—Skin disorder—Bupropion—obesity	3.39e-05	0.000331	CcSEcCtD
Fentanyl—Urinary tract infection—Topiramate—obesity	3.39e-05	0.000331	CcSEcCtD
Fentanyl—Conjunctivitis—Topiramate—obesity	3.39e-05	0.000331	CcSEcCtD
Fentanyl—Gastrointestinal pain—Orlistat—obesity	3.38e-05	0.000331	CcSEcCtD
Fentanyl—Hyperhidrosis—Bupropion—obesity	3.37e-05	0.00033	CcSEcCtD
Fentanyl—Anorexia—Bupropion—obesity	3.33e-05	0.000325	CcSEcCtD
Fentanyl—Haematuria—Topiramate—obesity	3.32e-05	0.000325	CcSEcCtD
Fentanyl—Feeling abnormal—Sibutramine—obesity	3.3e-05	0.000322	CcSEcCtD
Fentanyl—Epistaxis—Topiramate—obesity	3.29e-05	0.000321	CcSEcCtD
Fentanyl—Urticaria—Orlistat—obesity	3.29e-05	0.000321	CcSEcCtD
Fentanyl—Gastrointestinal pain—Sibutramine—obesity	3.27e-05	0.00032	CcSEcCtD
Fentanyl—Sinusitis—Topiramate—obesity	3.27e-05	0.00032	CcSEcCtD
Fentanyl—Abdominal pain—Orlistat—obesity	3.27e-05	0.00032	CcSEcCtD
Fentanyl—Body temperature increased—Orlistat—obesity	3.27e-05	0.00032	CcSEcCtD
Fentanyl—Hypotension—Bupropion—obesity	3.26e-05	0.000319	CcSEcCtD
Fentanyl—Bradycardia—Topiramate—obesity	3.19e-05	0.000311	CcSEcCtD
Fentanyl—Urticaria—Sibutramine—obesity	3.18e-05	0.000311	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Bupropion—obesity	3.18e-05	0.000311	CcSEcCtD
Fentanyl—Abdominal pain—Sibutramine—obesity	3.17e-05	0.000309	CcSEcCtD
Fentanyl—Body temperature increased—Sibutramine—obesity	3.17e-05	0.000309	CcSEcCtD
Fentanyl—Insomnia—Bupropion—obesity	3.16e-05	0.000308	CcSEcCtD
Fentanyl—Haemoglobin—Topiramate—obesity	3.15e-05	0.000307	CcSEcCtD
Fentanyl—Rhinitis—Topiramate—obesity	3.14e-05	0.000307	CcSEcCtD
Fentanyl—Paraesthesia—Bupropion—obesity	3.13e-05	0.000306	CcSEcCtD
Fentanyl—Haemorrhage—Topiramate—obesity	3.13e-05	0.000306	CcSEcCtD
Fentanyl—Hypoaesthesia—Topiramate—obesity	3.11e-05	0.000304	CcSEcCtD
Fentanyl—Hallucination—Topiramate—obesity	3.11e-05	0.000304	CcSEcCtD
Fentanyl—Dyspnoea—Bupropion—obesity	3.11e-05	0.000304	CcSEcCtD
Fentanyl—Pharyngitis—Topiramate—obesity	3.11e-05	0.000304	CcSEcCtD
Fentanyl—Somnolence—Bupropion—obesity	3.1e-05	0.000303	CcSEcCtD
Fentanyl—Urinary tract disorder—Topiramate—obesity	3.09e-05	0.000302	CcSEcCtD
Fentanyl—Oedema peripheral—Topiramate—obesity	3.08e-05	0.000301	CcSEcCtD
Fentanyl—Connective tissue disorder—Topiramate—obesity	3.08e-05	0.000301	CcSEcCtD
Fentanyl—Dyspepsia—Bupropion—obesity	3.07e-05	0.0003	CcSEcCtD
Fentanyl—Urethral disorder—Topiramate—obesity	3.07e-05	0.0003	CcSEcCtD
Fentanyl—Hypersensitivity—Orlistat—obesity	3.05e-05	0.000298	CcSEcCtD
Fentanyl—Decreased appetite—Bupropion—obesity	3.03e-05	0.000296	CcSEcCtD
Fentanyl—Visual impairment—Topiramate—obesity	3.02e-05	0.000295	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Bupropion—obesity	3.01e-05	0.000294	CcSEcCtD
Fentanyl—Fatigue—Bupropion—obesity	3.01e-05	0.000294	CcSEcCtD
Fentanyl—Pain—Bupropion—obesity	2.98e-05	0.000292	CcSEcCtD
Fentanyl—Constipation—Bupropion—obesity	2.98e-05	0.000292	CcSEcCtD
Fentanyl—Asthenia—Orlistat—obesity	2.97e-05	0.00029	CcSEcCtD
Fentanyl—Erythema multiforme—Topiramate—obesity	2.96e-05	0.000289	CcSEcCtD
Fentanyl—Hypersensitivity—Sibutramine—obesity	2.95e-05	0.000288	CcSEcCtD
Fentanyl—Pruritus—Orlistat—obesity	2.93e-05	0.000286	CcSEcCtD
Fentanyl—Eye disorder—Topiramate—obesity	2.93e-05	0.000286	CcSEcCtD
Fentanyl—Tinnitus—Topiramate—obesity	2.92e-05	0.000285	CcSEcCtD
Fentanyl—Flushing—Topiramate—obesity	2.91e-05	0.000284	CcSEcCtD
Fentanyl—Cardiac disorder—Topiramate—obesity	2.91e-05	0.000284	CcSEcCtD
Fentanyl—Feeling abnormal—Bupropion—obesity	2.88e-05	0.000281	CcSEcCtD
Fentanyl—Asthenia—Sibutramine—obesity	2.87e-05	0.000281	CcSEcCtD
Fentanyl—Gastrointestinal pain—Bupropion—obesity	2.85e-05	0.000279	CcSEcCtD
Fentanyl—Angiopathy—Topiramate—obesity	2.84e-05	0.000277	CcSEcCtD
Fentanyl—Pruritus—Sibutramine—obesity	2.83e-05	0.000277	CcSEcCtD
Fentanyl—Diarrhoea—Orlistat—obesity	2.83e-05	0.000277	CcSEcCtD
Fentanyl—Immune system disorder—Topiramate—obesity	2.83e-05	0.000276	CcSEcCtD
Fentanyl—Mediastinal disorder—Topiramate—obesity	2.82e-05	0.000276	CcSEcCtD
Fentanyl—Chills—Topiramate—obesity	2.81e-05	0.000274	CcSEcCtD
Fentanyl—Urticaria—Bupropion—obesity	2.77e-05	0.000271	CcSEcCtD
Fentanyl—Alopecia—Topiramate—obesity	2.77e-05	0.00027	CcSEcCtD
Fentanyl—Abdominal pain—Bupropion—obesity	2.76e-05	0.00027	CcSEcCtD
Fentanyl—Body temperature increased—Bupropion—obesity	2.76e-05	0.00027	CcSEcCtD
Fentanyl—Mental disorder—Topiramate—obesity	2.74e-05	0.000268	CcSEcCtD
Fentanyl—Diarrhoea—Sibutramine—obesity	2.74e-05	0.000268	CcSEcCtD
Fentanyl—Dizziness—Orlistat—obesity	2.74e-05	0.000267	CcSEcCtD
Fentanyl—Malnutrition—Topiramate—obesity	2.72e-05	0.000266	CcSEcCtD
Fentanyl—Erythema—Topiramate—obesity	2.72e-05	0.000266	CcSEcCtD
Fentanyl—Flatulence—Topiramate—obesity	2.69e-05	0.000262	CcSEcCtD
Fentanyl—Tension—Topiramate—obesity	2.67e-05	0.000261	CcSEcCtD
Fentanyl—Dysgeusia—Topiramate—obesity	2.67e-05	0.000261	CcSEcCtD
Fentanyl—Dizziness—Sibutramine—obesity	2.65e-05	0.000259	CcSEcCtD
Fentanyl—Nervousness—Topiramate—obesity	2.65e-05	0.000259	CcSEcCtD
Fentanyl—Back pain—Topiramate—obesity	2.64e-05	0.000258	CcSEcCtD
Fentanyl—Vomiting—Orlistat—obesity	2.63e-05	0.000257	CcSEcCtD
Fentanyl—Muscle spasms—Topiramate—obesity	2.62e-05	0.000256	CcSEcCtD
Fentanyl—Rash—Orlistat—obesity	2.61e-05	0.000255	CcSEcCtD
Fentanyl—Dermatitis—Orlistat—obesity	2.61e-05	0.000255	CcSEcCtD
Fentanyl—Headache—Orlistat—obesity	2.59e-05	0.000253	CcSEcCtD
Fentanyl—Hypersensitivity—Bupropion—obesity	2.57e-05	0.000251	CcSEcCtD
Fentanyl—Vision blurred—Topiramate—obesity	2.57e-05	0.000251	CcSEcCtD
Fentanyl—Tremor—Topiramate—obesity	2.55e-05	0.000249	CcSEcCtD
Fentanyl—Vomiting—Sibutramine—obesity	2.55e-05	0.000249	CcSEcCtD
Fentanyl—Ill-defined disorder—Topiramate—obesity	2.53e-05	0.000247	CcSEcCtD
Fentanyl—Rash—Sibutramine—obesity	2.52e-05	0.000247	CcSEcCtD
Fentanyl—Dermatitis—Sibutramine—obesity	2.52e-05	0.000246	CcSEcCtD
Fentanyl—Anaemia—Topiramate—obesity	2.52e-05	0.000246	CcSEcCtD
Fentanyl—Headache—Sibutramine—obesity	2.51e-05	0.000245	CcSEcCtD
Fentanyl—Asthenia—Bupropion—obesity	2.5e-05	0.000245	CcSEcCtD
Fentanyl—Agitation—Topiramate—obesity	2.5e-05	0.000245	CcSEcCtD
Fentanyl—Pruritus—Bupropion—obesity	2.47e-05	0.000241	CcSEcCtD
Fentanyl—Nausea—Orlistat—obesity	2.46e-05	0.00024	CcSEcCtD
Fentanyl—Malaise—Topiramate—obesity	2.46e-05	0.00024	CcSEcCtD
Fentanyl—Vertigo—Topiramate—obesity	2.45e-05	0.000239	CcSEcCtD
Fentanyl—Syncope—Topiramate—obesity	2.44e-05	0.000239	CcSEcCtD
Fentanyl—Leukopenia—Topiramate—obesity	2.44e-05	0.000238	CcSEcCtD
Fentanyl—Palpitations—Topiramate—obesity	2.41e-05	0.000235	CcSEcCtD
Fentanyl—Loss of consciousness—Topiramate—obesity	2.39e-05	0.000234	CcSEcCtD
Fentanyl—Diarrhoea—Bupropion—obesity	2.39e-05	0.000233	CcSEcCtD
Fentanyl—Nausea—Sibutramine—obesity	2.38e-05	0.000232	CcSEcCtD
Fentanyl—Cough—Topiramate—obesity	2.38e-05	0.000232	CcSEcCtD
Fentanyl—Convulsion—Topiramate—obesity	2.36e-05	0.000231	CcSEcCtD
Fentanyl—Hypertension—Topiramate—obesity	2.35e-05	0.00023	CcSEcCtD
Fentanyl—Chest pain—Topiramate—obesity	2.32e-05	0.000227	CcSEcCtD
Fentanyl—Myalgia—Topiramate—obesity	2.32e-05	0.000227	CcSEcCtD
Fentanyl—Arthralgia—Topiramate—obesity	2.32e-05	0.000227	CcSEcCtD
Fentanyl—Anxiety—Topiramate—obesity	2.31e-05	0.000226	CcSEcCtD
Fentanyl—Dizziness—Bupropion—obesity	2.31e-05	0.000226	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	2.3e-05	0.000225	CcSEcCtD
Fentanyl—Discomfort—Topiramate—obesity	2.29e-05	0.000224	CcSEcCtD
Fentanyl—Dry mouth—Topiramate—obesity	2.27e-05	0.000222	CcSEcCtD
Fentanyl—Confusional state—Topiramate—obesity	2.24e-05	0.000219	CcSEcCtD
Fentanyl—Oedema—Topiramate—obesity	2.22e-05	0.000217	CcSEcCtD
Fentanyl—Vomiting—Bupropion—obesity	2.22e-05	0.000217	CcSEcCtD
Fentanyl—Infection—Topiramate—obesity	2.21e-05	0.000216	CcSEcCtD
Fentanyl—Rash—Bupropion—obesity	2.2e-05	0.000215	CcSEcCtD
Fentanyl—Dermatitis—Bupropion—obesity	2.2e-05	0.000215	CcSEcCtD
Fentanyl—Shock—Topiramate—obesity	2.19e-05	0.000214	CcSEcCtD
Fentanyl—Headache—Bupropion—obesity	2.19e-05	0.000214	CcSEcCtD
Fentanyl—Nervous system disorder—Topiramate—obesity	2.18e-05	0.000213	CcSEcCtD
Fentanyl—Thrombocytopenia—Topiramate—obesity	2.18e-05	0.000213	CcSEcCtD
Fentanyl—Tachycardia—Topiramate—obesity	2.17e-05	0.000212	CcSEcCtD
Fentanyl—Skin disorder—Topiramate—obesity	2.16e-05	0.000211	CcSEcCtD
Fentanyl—Hyperhidrosis—Topiramate—obesity	2.15e-05	0.00021	CcSEcCtD
Fentanyl—Anorexia—Topiramate—obesity	2.12e-05	0.000207	CcSEcCtD
Fentanyl—Hypotension—Topiramate—obesity	2.08e-05	0.000203	CcSEcCtD
Fentanyl—Nausea—Bupropion—obesity	2.07e-05	0.000203	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Topiramate—obesity	2.03e-05	0.000198	CcSEcCtD
Fentanyl—Insomnia—Topiramate—obesity	2.01e-05	0.000197	CcSEcCtD
Fentanyl—Paraesthesia—Topiramate—obesity	2e-05	0.000195	CcSEcCtD
Fentanyl—Dyspnoea—Topiramate—obesity	1.98e-05	0.000194	CcSEcCtD
Fentanyl—Somnolence—Topiramate—obesity	1.98e-05	0.000193	CcSEcCtD
Fentanyl—Dyspepsia—Topiramate—obesity	1.96e-05	0.000191	CcSEcCtD
Fentanyl—Decreased appetite—Topiramate—obesity	1.93e-05	0.000189	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Topiramate—obesity	1.92e-05	0.000188	CcSEcCtD
Fentanyl—Fatigue—Topiramate—obesity	1.92e-05	0.000187	CcSEcCtD
Fentanyl—Constipation—Topiramate—obesity	1.9e-05	0.000186	CcSEcCtD
Fentanyl—Pain—Topiramate—obesity	1.9e-05	0.000186	CcSEcCtD
Fentanyl—Feeling abnormal—Topiramate—obesity	1.83e-05	0.000179	CcSEcCtD
Fentanyl—Gastrointestinal pain—Topiramate—obesity	1.82e-05	0.000178	CcSEcCtD
Fentanyl—Urticaria—Topiramate—obesity	1.77e-05	0.000173	CcSEcCtD
Fentanyl—Body temperature increased—Topiramate—obesity	1.76e-05	0.000172	CcSEcCtD
Fentanyl—Abdominal pain—Topiramate—obesity	1.76e-05	0.000172	CcSEcCtD
Fentanyl—Hypersensitivity—Topiramate—obesity	1.64e-05	0.00016	CcSEcCtD
Fentanyl—Asthenia—Topiramate—obesity	1.6e-05	0.000156	CcSEcCtD
Fentanyl—Pruritus—Topiramate—obesity	1.57e-05	0.000154	CcSEcCtD
Fentanyl—Diarrhoea—Topiramate—obesity	1.52e-05	0.000149	CcSEcCtD
Fentanyl—Dizziness—Topiramate—obesity	1.47e-05	0.000144	CcSEcCtD
Fentanyl—Vomiting—Topiramate—obesity	1.41e-05	0.000138	CcSEcCtD
Fentanyl—Rash—Topiramate—obesity	1.4e-05	0.000137	CcSEcCtD
Fentanyl—Dermatitis—Topiramate—obesity	1.4e-05	0.000137	CcSEcCtD
Fentanyl—Headache—Topiramate—obesity	1.39e-05	0.000136	CcSEcCtD
Fentanyl—Nausea—Topiramate—obesity	1.32e-05	0.000129	CcSEcCtD
Fentanyl—ABCB1—Metabolism—CETP—obesity	2.94e-06	6.37e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IRS1—obesity	2.93e-06	6.35e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GLUL—obesity	2.93e-06	6.35e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—FABP4—obesity	2.93e-06	6.35e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AGT—obesity	2.92e-06	6.32e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SDC1—obesity	2.91e-06	6.3e-05	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	2.89e-06	6.25e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TYK2—obesity	2.86e-06	6.2e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKR1C3—obesity	2.86e-06	6.2e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOE—obesity	2.86e-06	6.19e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IRS2—obesity	2.84e-06	6.15e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RHOA—obesity	2.84e-06	6.15e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AGT—obesity	2.83e-06	6.14e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CAV1—obesity	2.83e-06	6.14e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOA1—obesity	2.82e-06	6.12e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—POMC—obesity	2.82e-06	6.12e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SCARB1—obesity	2.81e-06	6.1e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3R1—obesity	2.81e-06	6.09e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOS3—obesity	2.81e-06	6.09e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—INS—obesity	2.81e-06	6.09e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ECHS1—obesity	2.78e-06	6.02e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—UCP3—obesity	2.78e-06	6.02e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HSD11B1—obesity	2.78e-06	6.02e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—UCP2—obesity	2.78e-06	6.02e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LEP—obesity	2.78e-06	6.02e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOE—obesity	2.78e-06	6.02e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCL2—obesity	2.76e-06	5.99e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CAV1—obesity	2.75e-06	5.96e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOA1—obesity	2.75e-06	5.95e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—COMT—obesity	2.74e-06	5.95e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ADH1B—obesity	2.73e-06	5.93e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SREBF1—obesity	2.73e-06	5.92e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1—obesity	2.72e-06	5.89e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT2—obesity	2.71e-06	5.88e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GNB3—obesity	2.71e-06	5.87e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARGC1A—obesity	2.71e-06	5.87e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HMOX1—obesity	2.69e-06	5.84e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPAM—obesity	2.69e-06	5.83e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ACSL1—obesity	2.69e-06	5.83e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARGC1B—obesity	2.69e-06	5.83e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CA—obesity	2.67e-06	5.8e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GOT2—obesity	2.66e-06	5.76e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ESR1—obesity	2.65e-06	5.75e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GNAS—obesity	2.63e-06	5.71e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—F2—obesity	2.62e-06	5.68e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PRKCB—obesity	2.62e-06	5.68e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PCK1—obesity	2.61e-06	5.66e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HADH—obesity	2.61e-06	5.66e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—FADS1—obesity	2.61e-06	5.66e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CD—obesity	2.61e-06	5.65e-05	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ALB—obesity	2.61e-06	5.65e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—FASN—obesity	2.6e-06	5.64e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CB—obesity	2.59e-06	5.62e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MTOR—obesity	2.59e-06	5.62e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—BCHE—obesity	2.59e-06	5.61e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—BAD—obesity	2.59e-06	5.61e-05	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CA—obesity	2.58e-06	5.6e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOB—obesity	2.58e-06	5.59e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SERPINE1—obesity	2.58e-06	5.59e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CG—obesity	2.58e-06	5.59e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ACP5—obesity	2.54e-06	5.51e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TYK2—obesity	2.51e-06	5.44e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CG—obesity	2.51e-06	5.43e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP2E1—obesity	2.5e-06	5.42e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARG—obesity	2.49e-06	5.39e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RHOA—obesity	2.49e-06	5.39e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IRS1—obesity	2.48e-06	5.37e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—G6PD—obesity	2.48e-06	5.37e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NQO1—obesity	2.47e-06	5.36e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—LPL—obesity	2.46e-06	5.34e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3R1—obesity	2.46e-06	5.34e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOS3—obesity	2.46e-06	5.34e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—POMC—obesity	2.45e-06	5.32e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SREBF2—obesity	2.45e-06	5.3e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HK1—obesity	2.45e-06	5.3e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—INS—obesity	2.44e-06	5.29e-05	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—AKT1—obesity	2.41e-06	5.21e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GPX1—obesity	2.4e-06	5.21e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—POMC—obesity	2.39e-06	5.17e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—INS—obesity	2.37e-06	5.14e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC2A4—obesity	2.37e-06	5.14e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GCG—obesity	2.37e-06	5.14e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—obesity	2.37e-06	5.13e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LPA—obesity	2.36e-06	5.12e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CA—obesity	2.34e-06	5.08e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CD36—obesity	2.34e-06	5.07e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYCS—obesity	2.34e-06	5.07e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCL2—obesity	2.33e-06	5.06e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LPIN1—obesity	2.31e-06	5.01e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1—obesity	2.29e-06	4.97e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GGT1—obesity	2.29e-06	4.97e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GOT1—obesity	2.29e-06	4.97e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT2—obesity	2.29e-06	4.97e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CB—obesity	2.27e-06	4.93e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MTOR—obesity	2.27e-06	4.93e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CD—obesity	2.27e-06	4.91e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOA5—obesity	2.26e-06	4.91e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NCOA1—obesity	2.26e-06	4.9e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—obesity	2.25e-06	4.88e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALB—obesity	2.24e-06	4.85e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—STK11—obesity	2.23e-06	4.83e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP19A1—obesity	2.23e-06	4.83e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MTHFR—obesity	2.22e-06	4.81e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CD—obesity	2.2e-06	4.78e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK8—obesity	2.19e-06	4.75e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—AKT1—obesity	2.18e-06	4.74e-05	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CA—obesity	2.18e-06	4.73e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SERPINE1—obesity	2.18e-06	4.72e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARA—obesity	2.18e-06	4.72e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CLOCK—obesity	2.16e-06	4.68e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC22A1—obesity	2.16e-06	4.68e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NOS3—obesity	2.14e-06	4.64e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3R1—obesity	2.14e-06	4.64e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TYK2—obesity	2.12e-06	4.59e-05	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—AKT1—obesity	2.11e-06	4.57e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AGT—obesity	2.11e-06	4.57e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SULT2A1—obesity	2.11e-06	4.56e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GLP1R—obesity	2.11e-06	4.56e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RHOA—obesity	2.1e-06	4.56e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOS3—obesity	2.08e-06	4.51e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3R1—obesity	2.08e-06	4.51e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—obesity	2.08e-06	4.5e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—DPYD—obesity	2.07e-06	4.49e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—COMT—obesity	2.07e-06	4.49e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOE—obesity	2.06e-06	4.48e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CAV1—obesity	2.05e-06	4.43e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARGC1A—obesity	2.04e-06	4.43e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GNB3—obesity	2.04e-06	4.43e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOA1—obesity	2.04e-06	4.42e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMOX1—obesity	2.03e-06	4.41e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STAT3—obesity	2e-06	4.34e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PRKAR2B—obesity	1.99e-06	4.32e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GNAS—obesity	1.99e-06	4.31e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CA—obesity	1.98e-06	4.3e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—DCN—obesity	1.98e-06	4.29e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CB—obesity	1.98e-06	4.28e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—obesity	1.97e-06	4.28e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—obesity	1.96e-06	4.24e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOB—obesity	1.95e-06	4.22e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CPT1A—obesity	1.93e-06	4.17e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK8—obesity	1.92e-06	4.16e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MTOR—obesity	1.92e-06	4.16e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CB—obesity	1.92e-06	4.16e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—AKT1—obesity	1.92e-06	4.15e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NAMPT—obesity	1.89e-06	4.09e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LIPC—obesity	1.88e-06	4.07e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GCK—obesity	1.88e-06	4.07e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOC3—obesity	1.86e-06	4.04e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CG—obesity	1.86e-06	4.04e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MYC—obesity	1.86e-06	4.03e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LPL—obesity	1.86e-06	4.03e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFB1—obesity	1.86e-06	4.02e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GPX1—obesity	1.81e-06	3.93e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CETP—obesity	1.81e-06	3.92e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARG—obesity	1.8e-06	3.9e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SDC1—obesity	1.79e-06	3.88e-05	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT1—obesity	1.78e-06	3.86e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—POMC—obesity	1.77e-06	3.85e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CD36—obesity	1.77e-06	3.83e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—INS—obesity	1.76e-06	3.82e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKR1C3—obesity	1.76e-06	3.82e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STAT3—obesity	1.76e-06	3.81e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—obesity	1.75e-06	3.8e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SCARB1—obesity	1.73e-06	3.76e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SREBF1—obesity	1.68e-06	3.65e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MTHFR—obesity	1.67e-06	3.63e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—obesity	1.67e-06	3.62e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARA—obesity	1.64e-06	3.56e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CD—obesity	1.64e-06	3.55e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GOT2—obesity	1.64e-06	3.55e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MYC—obesity	1.63e-06	3.54e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFB1—obesity	1.63e-06	3.53e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK8—obesity	1.62e-06	3.52e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT1—obesity	1.62e-06	3.51e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALB—obesity	1.62e-06	3.51e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—FASN—obesity	1.6e-06	3.47e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—BCHE—obesity	1.6e-06	3.46e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AGT—obesity	1.59e-06	3.45e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CA—obesity	1.58e-06	3.42e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOE—obesity	1.56e-06	3.38e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3R1—obesity	1.55e-06	3.35e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NOS3—obesity	1.55e-06	3.35e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CAV1—obesity	1.54e-06	3.35e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOA1—obesity	1.54e-06	3.34e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2E1—obesity	1.54e-06	3.34e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NQO1—obesity	1.52e-06	3.3e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STAT3—obesity	1.48e-06	3.22e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GCG—obesity	1.46e-06	3.16e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC2A4—obesity	1.46e-06	3.16e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYCS—obesity	1.44e-06	3.12e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CB—obesity	1.43e-06	3.1e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—obesity	1.41e-06	3.07e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GGT1—obesity	1.41e-06	3.06e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GOT1—obesity	1.41e-06	3.06e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CG—obesity	1.41e-06	3.05e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—obesity	1.4e-06	3.03e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NCOA1—obesity	1.39e-06	3.02e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CA—obesity	1.39e-06	3e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MYC—obesity	1.38e-06	2.99e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFB1—obesity	1.38e-06	2.98e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP19A1—obesity	1.37e-06	2.97e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—STK11—obesity	1.37e-06	2.97e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARG—obesity	1.36e-06	2.94e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—POMC—obesity	1.34e-06	2.9e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—INS—obesity	1.33e-06	2.89e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT1—obesity	1.29e-06	2.8e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—COMT—obesity	1.28e-06	2.77e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GNB3—obesity	1.26e-06	2.73e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARGC1A—obesity	1.26e-06	2.73e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMOX1—obesity	1.25e-06	2.71e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CD—obesity	1.24e-06	2.68e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—obesity	1.23e-06	2.66e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GNAS—obesity	1.22e-06	2.65e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALB—obesity	1.22e-06	2.65e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CA—obesity	1.2e-06	2.61e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOB—obesity	1.2e-06	2.6e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CA—obesity	1.17e-06	2.54e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NOS3—obesity	1.17e-06	2.53e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3R1—obesity	1.17e-06	2.53e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LPL—obesity	1.15e-06	2.48e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT1—obesity	1.13e-06	2.45e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPX1—obesity	1.12e-06	2.42e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CD36—obesity	1.09e-06	2.36e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CB—obesity	1.08e-06	2.34e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—obesity	1.07e-06	2.31e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—obesity	1.04e-06	2.25e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTHFR—obesity	1.03e-06	2.24e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARA—obesity	1.01e-06	2.19e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKT1—obesity	9.84e-07	2.13e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AGT—obesity	9.8e-07	2.12e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOE—obesity	9.6e-07	2.08e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT1—obesity	9.56e-07	2.07e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CAV1—obesity	9.51e-07	2.06e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOA1—obesity	9.49e-07	2.06e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CA—obesity	8.7e-07	1.89e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CG—obesity	8.66e-07	1.88e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARG—obesity	8.36e-07	1.81e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—POMC—obesity	8.25e-07	1.79e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—INS—obesity	8.2e-07	1.78e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CD—obesity	7.62e-07	1.65e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALB—obesity	7.52e-07	1.63e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3R1—obesity	7.19e-07	1.56e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NOS3—obesity	7.19e-07	1.56e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKT1—obesity	7.11e-07	1.54e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CB—obesity	6.64e-07	1.44e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—obesity	6.58e-07	1.43e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CA—obesity	6.57e-07	1.42e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKT1—obesity	5.37e-07	1.16e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CA—obesity	4.05e-07	8.77e-06	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKT1—obesity	3.31e-07	7.17e-06	CbGpPWpGaD
